From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT scans, and MRIs.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

As though diabetes, obesity, or hypertension alone would be bad enough, all three conditions together are bad news and a ...

The grant will aid in carrying out laparoscopic surgical electrode implantation approaches and studies in a porcine model.